A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. Herman L, Amo A, Legois B, Di Carlo C, et al. Br J Cancer 2024;130:1453-1462.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Herman L, Amo A, Legois B, Di Carlo C, et al. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. Br J Cancer 2024;130:1453-1462.
PMID: 38429437